Expression of hyaluronic acid in N-nitrosodimethylamine induced hepatic fibrosis in rats

International Journal of Biochemistry and Cell Biology

Volumn 36, Issue 2, 2004, Pages 307-319

  George, Joseph ^a   Tsutsumi, Mikihiro ^a   Takase, Shujiro ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

CD44; Hepatic fibrosis; Hyaluronic acid; Liver cirrhosis; N nitrosodimethylamine; Stellate cells

Indexed keywords

ALPHA ACTIN; DIMETHYLNITROSAMINE; HERMES ANTIGEN; HYALURONIC ACID;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CELL ACTIVATION; ENDOTHELIUM CELL; HISTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER NECROSIS; MALE; MONITORING; NONHUMAN; RAT; SMOOTH MUSCLE; STELLATE CELL;

ANIMALIA;

EID: 0344413735     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(03)00253-X     Document Type: Article

References (44)

1. Aruffo A., Stamenkovic I., Melnick M., Underhill C.B., Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 61:1990;1303-1313.
2. Brenner D.A., Waterboer T., Choi S.K., Lindquist J.N., Stefanovic B., Burchardt E., Yamauchi M., Gillan A., Rippe R.A. New aspects of hepatic fibrosis. Journal of Hepatology. 32(Suppl 1):2000;32-38.
3. Burt A.D., Oakely C.L. Lecture (1993): Cellular and molecular aspects of hepatic fibrosis. Journal of Pathology. 170:1993;105-114.
4. Chichibu K., Matsuura T., Shichijo S., Yokoyama M.M. Assay of serum hyaluronic acid in clinical application. Clinica Chimica Acta. 181:1989;317-323.
5. Eriksson S., Fraser J.R.E., Laurent T.C., Pertoft H., Smedsrod B. Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver. Experimental Cell Research. 144:1983;223-228.
6. Fraser J.R., Alcorn D., Laurent T.C., Robinson A.D., Ryan G.B. Uptake of circulating hyaluronic acid by the rat liver. Cellular localization in situ. Cell Tissue Research. 242:1985;505-510.
7. Friedman S.L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. Journal of Biological Chemistry. 275:2000;2247-2250.
8. George J., Chandrakasan G. Glycoprotein metabolism in dimethylnitrosamine induced hepatic fibrosis in rats. International Journal of Biochemical Cell Biology. 28:1996a;353-361.
9. George J., Chandrakasan G. Molecular characteristics of dimethylnitrosamine induced fibrotic liver collagen. Biochimica Biophysica Acta. 1292:1996b;215-222.
10. George J., Chandrakasan G. Biochemical abnormalities during the progression of hepatic fibrosis induced by dimethylnitrosamine. Clinical Biochemistry. 33:2000;563-570.
11. Gressner A.M., Haarmann R. Regulation of hyaluronate synthesis in rat liver fat storing cell cultures by Kupffer cells. Journal of Hepatology. 7:1988a;310-318.
12. Gressner A.M., Haarmann R. Hyaluronic acid synthesis and secretion by rat liver fat storing cells (perisinusoidal lipocytes) in culture. Biochemical and Biophysical Research Communication. 151:1988b;222-229.
13. George J., Rao K.R., Stern R., Chandrakasan G. Dimethylnitrosamine- induced liver injury in rats: The early deposition of collagen. Toxicology. 156:2001;129-138.
14. Grzeszczuk A., Chlabicz S., Panasiuk A. Serum hyaluronan as a possible biomarker of liver insufficiency in cirrhotic patients. Roczniki Akademie Medizinischen w Bialymstoku. 47:2002;80-85.
15. Hasegawa T., Sasaki T., Kimura T., Hoki M., Okada A., Mushiake S., Yagi M., Imura K. Measurement of serum hyaluronic acid as a sensitive marker of liver fibrosis in biliary atresia. Journal of Pediatric Surgery. 35:2000;1643-1646.
16. Heinegard, D., Paulsson, M. (1984). Structure and metabolism of proteoglycans. In K. A. Piez, A. H. Reddi (Eds.), Extracellular matrix biochemistry (pp. 277-328). New York: Elsevier.
17. Jenkins S.A., Grandison A., Baxter J.N., Day D.W., Taylor I., Shields R. A dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the rat. Journal of Hepatology. 1:1985;489-499.
18. Jezequel A.M., Mancini R., Rinaldesi M.L., Macarri G., Venturini C., Orlandi F. A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat. Journal of Hepatology. 5:1987;174-181.
19. Kobayashi H., Horikoshi K., Yamataka A., Yamataka T., Okazaki T., Lane G.J., Miyano T. Hyaluronic acid: A specific prognostic indicator of hepatic damage in biliary atresia. Journal of Pediatric Surgery. 34:1999;1791-1794.
20. Korner T., Kropf J., Gressner A.M. Serum laminin and hyaluronan in liver cirrhosis: Markers of progression with high prognostic value. Journal of Hepatology. 25:1996;684-688.
21. Lee J.Y., Spicer A.P. Hyaluronan: A multifunctional, megaDalton, stealth molecule. Current Opinion Cell Biology. 12:2000;581-586.
22. Lesley J., Hyman R. CD44 structure and function. Front Bioscience. 3:1998;D616-D630.
23. Magee P.N., Barnes J. Carcinogenic compounds. Advanced Cancer Research. 10:1967;163-246.
24. Nanji A.A., Tahan S.R., Khwaja S., Yacoub L.K., Sadrzadeh S.M. Elevated plasma levels of hyaluronic acid indicate endothelial cell dysfunction in the initial stages of alcoholic liver disease in the rat. Journal of Hepatology. 24:1996;368-374.
25. Naot D., Sionov R.V., Ish-Shalom D. CD44: Structure, function, and association with the malignant process. Advanced Cancer Research. 71:1997;241-319.
26. Nyberg A., Engstrom-Laurent A., Loof L. Serum hyaluronate in primary biliary cirrhosis - a biochemical marker for progressive liver damage. Hepatology. 8:1988;142-146.
27. Patel K., Lajoie A., Heaton S., Pianko S., Behling C.A., Bylund D., Pockros P.J., Blatt L.M., Conrad A., McHutchison J.G. Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C. Journal of Gastroenterology Hepatology. 18:2003;253-257.
28. Plevris J.N., Haydon G.H., Simpson K.J., Dawkes R., Ludlum C.A., Harrison D.J., Hayes P.C. Serum hyaluronan - a non-invasive test for diagnosing liver cirrhosis. European Journal of Gastroenterology Hepatology. 12:2000;1121-1127.
29. Rockey D.C., Boyles J.K., Gabbiani G., Friedman S.L. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. Journal of Submicroscopic Cytology Pathology. 24:1992;193-203.
30. Saegusa S., Isaji S., Kawarada Y. Changes in serum hyaluronic acid levels and expression of CD44 and CD44 mRNA in hepatic sinusoidal endothelial cells after major hepatectomy in cirrhotic rats. World Journal of Surgery. 26:2002;694-699.
31. Satoh T., Ichida T., Matsuda Y., Sugiyama M., Yonekura K., Ishikawa T., Asakura H. Interaction between hyaluronan and CD44 in the development of dimethylnitrosamine-induced liver cirrhosis. Journal of Gastroenterology Hepatology. 15:2000;402-411.
32. Scoazec J.-Y. Expression of cell-matrix adhesion molecules in the liver and their modulation during fibrosis. Journal of Hepatology. 22(Suppl 2):1995;20-27.
33. Sherman L., Sleeman J., Herrlich P., Ponta H. Hyaluronate receptors: Key players in growth, differentiation, migration and tumor progression. Current Opinion in Cell Biology. 6:1994;726-733.
34. Shiba M., Shimizu I., Yasuda M., Ii K., Ito S. Expression of type I and type III collagens during the course of dimethylnitrosamine-induced hepatic fibrosis in rats. Liver. 18:1998;196-204.
35. Stickel F., Urbaschek R., Schuppan D., Poeschl G., Oesterling C., Conradt C., McCuskey R.S., Simanowski U.A., Seitz H.K. Serum collagen type VI and XIV and hyaluronic acid as early indicators for altered connective tissue turnover in alcoholic liver disease. Digestive Disease and Sciences. 46:2001;2025-2032.
36. Tamaki S., Ueno T., Torimura T., Sata M., Tanikawa K. Evaluation of hyaluronic acid binding ability of hepatic sinusoidal endothelial cells in rats with liver cirrhosis. Gastroenterology. 111:1996;1049-1057.
37. Toole B.P. Hyaluronan in morphogenesis. Seminars in Cell and Developmental Biology. 12:2001;79-87.
38. Tsutsumi R., Leo M.A., Kim C.I., Tsutsumi M., Lasker J., Lowe N., Lieber C.S. Interaction of ethanol with enflurane metabolism and toxicity role: Of P450IIE1. Alcohol Clinical and Experimental Research. 14:1990;174-179.
39. Tsutsumi M., Urashima S., Takase S., Ueshima Y., Tsuchishima M., Shimanaka K., Kawahara H. Characteristics of serum hyaluronate concentrations in patients with alcoholic liver disease. Alcohol Clinical and Experimental Research. 21:1997;1716-1721.
40. Ueno T., Inuzuka S., Torimura T., Tamaki S., Koh H., Kin M., Minetoma T., Kimura Y., Ohira H., Sata M., Yoshida H., Tanikawa K. Serum hyaluronate reflects hepatic sinusoidal capillarization. Gastroenterology. 105:1993;475-481.
41. Urashima S., Tsutsumi M., Shimanaka K., Ueshima Y., Tsuchishima M., Itoh T., Kawahara H., Takase S. Histochemical study of hyaluronate in alcoholic liver disease. Alcohol Clinical and Experimental Research. 23(Suppl 4):1999;56S-60S.
42. Urashima S., Tsutsumi M., Ozaki K., Tsuchishima M., Shimanaka K., Ueshima Y., Takase S. Immunohistochemical study of hyaluronate receptor (CD44) in alcoholic liver disease. Alcohol Clinical and Experimental Research. 24:2000;34s-38s.
43. Vrochides D., Papanikolaou V., Pertoft H., Antoniades A.A., Heldin P. Biosynthesis and degradation of hyaluronan by nonparenchymal liver cells during liver regeneration. Hepatology. 23:1996;1650-1655.
44. Yasuda M., Nakano K., Yasumoto K., Tanaka Y. CD44: Functional relevance to inflammation and malignancy. Histology Histopathology. 17:2002;945-950.